Advancements in Endocrine Therapy for ER-Positive Breast Cancer

This chapter delves into dosing guidelines and monitoring of blood glucose levels for a specific drug in breast cancer treatment. It also explores future anti-estrogen agents, ESR1 mutations, and resistance mechanisms in ER-positive metastatic breast cancer. Updates from a conference, ongoing trials, and comparisons between different treatment approaches highlight the progress in overcoming endocrine resistance.